Prof. Dr. Nuri Faruk Aykan

Makaleler

• Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey , 2022
• Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors? , 2014
• Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients , 2019
• Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. , 2001
• A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. , 1998
• Prognostic significance of the metastatic lymph node ratio for survival in colon cancer , 2011
• A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma , 2011
• Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients , 2014
• Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study , 2016
• Clinical significance of serum interleukin-17 levels in colorectal cancer patients , 2016
• Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: a family report , 2017
• Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers , 2018
• Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study , 2018
• Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study , 2018
• CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA , 2017
• Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer , 2017
• CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIALBIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA , 2017
• Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers. , 2017
• Effect of increased body mass index BMI on time to tumour progression TTP in unresectable metastatic colorectal cancer mCRC patients treated with bevacizumab based therapy , 2013
• Serum neural precursor cell expressed developmentally down regulated 9 NEDD9 level may have a prognostic role in patients with gastric cancer , 2015
• Red meat and colorectal cancer , 2016
• Red meat subtypes and colorectal cancer risk , 2015
• Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients , 2009
• The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival , 2000
• The role of UFT in advanced gastric cancer , 2008
• Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer , 2004
• Prognostic Factors in Pancreatic Carcinoma Serum LDH Levels Predict Survival in Metastatic Disease , 2001
• Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection can we avoid radiotherapy in a subgroup of patients , 2013
• Penile metastasis of cutaneous malignant melanoma a true hematogenous spread Case report and review of the literature , 2006
• Clinical significance of serum claudin 1 and claudin 7 levels in patients with colorectal cancer , 2015
• Evaluation of Serum Interleukin 17 IL 17 Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma , 2015
• Serum nectin 2 levels are diagnostic and prognostic in patients with colorectal carcinoma , 2015
• Epidemiology of colorectal cancer in Turkey A cross sectional disease registry study A Turkish Oncology Group trial , 2015